Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$274.66 USD
-8.42 (-2.97%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $274.50 -0.16 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
A Value F Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
For Elevance Health, Inc., the company has a dividend yield of 2.42% compared to the Medical Services industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ELV 274.66 -8.42(-2.97%)
Will ELV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELV
Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength?
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Optum Support UnitedHealth's Profit Amid Industry Headwinds?
Medical Expenses Erode Centene's Bottom Line in Rare Q2 Earnings Miss
Company News for Jul 18, 2025
Other News for ELV
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
UnitedHealth sets 2025 outlook below consensus amid rising medical costs
UnitedHealth stumbles on weak profit outlook, drags peers lower
UnitedHealth stumbles as annual profit outlook disappoints
UnitedHealth Stock Is A Strong Buy Amid Unfavorable Medical Trends (Upgrade)